Group items tagged

Community Pharmacy England (CPE) has taken an interesting step to increase public awareness and understanding of the Pharmacy First service. The organisation has launched a new video animation that provides clear and concise information about the service, highlighting the seven conditions covered, the eligible age ranges within the clinical pathways consultations, and explaining how patients can access these services. Pharmacy owners and their teams are encouraged to use the new animation with existing resources to communicate the benefits and scope of the service to their  patients. The animation can be linked to pharmacy social media content and downloaded for display on digital screens in pharmacies. General practices are also encouraged to use the animation on digital screens in their practice waiting areas.

Governments should invest in vaccines for all strains of influenza virus that exist in the animal kingdom as an insurance policy in case of an outbreak in humans, the incoming chief scientist at the World Health Organization said on Monday (Feb. 20). Countries ranging from the United States and Britain to France and Japan have suffered record losses of poultry in outbreaks of avian flu in the past year. The recent spread to mammals of H5N1 - commonly known as bird flu - needed to be monitored, but the risk to humans remained low, the WHO said earlier this month. Incoming WHO chief scientist Jeremy Farrar said he would like to see the pharmaceutical industry at least conduct some clinical trials for all influenza strains such that the world would not have to start from scratch to initiate global manufacturing should the need arise. "My concern that we're in slow motion watching something which may never happen," he added in a media briefing. "But if it were to happen, would we look back on what we're doing at the moment and say, why didn't we do more?"

The subject of today's article is the benefits and uses of Tripeptide-29. Let's dive right into it! The three-amino-acid peptide known as Tripeptide-29 consists of glycine, proline, and hydroxyproline amino acids. Collagen peptide is another frequent name for this peptide since it occurs naturally in animal collagen. Animal studies have indicated that topical Tripeptide 29 may minimize the look of fine lines and wrinkles, enhance the skin's texture, and replenish moisture in dry areas. Experts are now studying the effects of Tripeptide on the skin. Place your order now if you need collagen peptide for a study. Continue reading for more information on this peptide. What is the function of Tripeptide 29? One of collagen's primary structural components, Tripeptide-29, is a synthetic peptide. Collagen is the most common protein in the animal body and is essential in developing and maintaining healthy hair, skin, nails, tendons, ligaments, and bones. Glycine, proline, and hydroxyproline are the building blocks of this long-chain polymer. The Gly-Pro-Hyp peptide Tripeptide-29 is a vital part of type 1 collagen.

The Food Standards Agency (FSA) has launched a campaign to caution people with food allergies about the risk of products labelled as 'vegan'. People who have an allergy to milk, eggs, fish and crustaceans or molluscs are encouraged to always check for a precautionary allergen statement such as 'may contain' on products labelled 'vegan' before consuming the food. The launch of the campaign comes in the wake of recent research findings by the FSA that 62 per cent of individuals with reactions to animal-based products or who buy for someone with allergies were confident that products labelled 'vegan' are safe to eat. This is "incorrect" and may put them at risk, the agency said. The FSA study found that 54 per cent of people who experience reactions to animal-based products and 53 per cent of those purchasing for someone with a food hypersensitivity to animal-origin products have used vegan labelling to determine the safety of packaged food on at least some occasions.

From tracking Polar bears, Arctic fox, and ringed seal to swimming with sea lions, penguins, whales and seals in the Sea of Cortez, the world is full of incredible wildlife adventures that you need to experience at least once. If you are a sucker for animals, you won't want to miss these unforgettable wildlife vacations. The wonders of nature are spread in the forms of forests, waterfalls, flowering pastures, mountains, rivers and valleys. When wild life enters the beautiful nature, it attracts travelers from far and near. The natural spectrum of wild lands always encourages people to travel the scenic lands. In this way, tourists explore the way to enjoy life from a different angle.

Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma. Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General Manager, India. Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey. She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling healthcare inequalities and advancing sustainable healthcare. Commenting on her new role, Manja said: "It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland."

Olbas has announced the launch of its new TV ad campaign which will debut across the country this October. The TV campaign, which will be supported by a £1.5 million pound media investment, has been directed by commercial film director, Anthony Farquhar-Smith. The latest Olbas advertising creative will feature a new animated character, Lauren who is suffering with congestion caused by a cold. Lauren will be seen at home as the house begins to fill with balloons causing Lauren to feel uncomfortable and restricted, mimicking the 'bunged up' feeling of a heavy head cold. Olbas then saves the day as we see Lauren reach for a bottle of Olbas Oil to ease the symptoms of congestion, and as a result, the balloons deflate and the house returns to normal. Along with the large media investment, the campaign will also benefit from a strong PR programme to ensure the brand and retail sales are well supported throughout the peak cold and flu season. Owned by family-run health business, Lanes Health, Olbas Oil continues to be manufactured at their Gloucester based factory. Olbas uses only natural essential oils to provide a gentle but effective formulation to ease congestion and enhance breathing passages. The product offer includes Olbas Oil, Olbas For Children, Olbas Inhaler, Olbas Nasal Spray, Olbas Menthol Pastilles and Olbas Bath.

Maintaining good personal hygiene is among the most effective defenses against gastrointestinal and infectious disorders such as the flu, and the common cold. By using soap and water to wash your hands, you can prevent the spread of germs that can make you sick. When it comes to your own health, basic personal hygiene can also assist protect you from infecting others. A typical personal hygiene consists of following habits: Every day, washing your face and body Washing your hands after using the bathroom with soap Twice daily cleaning of the teeth When you sneeze or cough, using a tissue (or your sleeve) to cover your mouth and nose After touching pets and other animals, cleaning your hands Here's what you can do to reduce the spread of infection through a basic personal hygiene: Keeping Food In A Safe Environment Before and after cooking, wash your hands. Thus, you won't be able to contaminate food and won't get sick or spread bacteria from food, such as raw meat

The UK government on Thursday (8 May) launched a new plan to tackle antimicrobial resistance (AMR), a global issue that makes infections difficult or impossible to treat. This is the second phase of a series of 5-year national action plans, aimed at supporting the government's 20-year vision to contain and control AMR by 2040. With the launch of this new national action plan, the UK commits to reducing its use of antimicrobials - such as antibiotics, antifungals and antivirals - in humans and animals. Additionally, it aims to strengthen surveillance of drug-resistant infections before they emerge and incentivise industry to develop the next generation of treatments. There are also plans to expand initiatives such as the world-first 'subscription model' for antimicrobials, launched in 2019 as a pilot.